← Back to Search

Antibiotic

Antibiotics for Preventing Infections After Kidney Stone Treatment (STENTABX Trial)

N/A
Recruiting
Research Sponsored by University of California, San Diego
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients having undergone kidney stone treatment surgery (shockwave lithotripsy [SWL], ureteroscopy [URS], retrograde intrarenal surgery [RIRS], percutaneous nephrolithotomy [PNL])
Age: >=18 years of age
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days
Awards & highlights

STENTABX Trial Summary

This trial will study whether a single dose of Ciprofloxicin, an antibiotic, can prevent infection after ureteral stent removal. The control group will not receive any antibiotics.

Who is the study for?
This trial is for adults over 18 who've had recent kidney stone treatment surgery and have a ureteral stent placed within the last two weeks. It includes all ethnicities, with an expected mix of 60% men and 40% women. Excluded are those with catheters, pregnant women, or patients performing clean intermittent catheterization.Check my eligibility
What is being tested?
The study tests if taking a single dose of Ciprofloxacin (an antibiotic) can prevent infections when removing ureteral stents after kidney stone treatments. Participants will be randomly assigned to receive either the antibiotic or no intervention during stent removal.See study design
What are the potential side effects?
Potential side effects from Ciprofloxacin may include nausea, diarrhea, dizziness, and allergic reactions. Not everyone will experience these side effects; some might not have any at all.

STENTABX Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have had surgery for kidney stones.
Select...
I am 18 years old or older.

STENTABX Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Post-procedure Infectious Complication
Secondary outcome measures
Patient Risk Factors Predisposing to Post-procedure Infectious Complications

STENTABX Trial Design

2Treatment groups
Active Control
Group I: AntibioticActive Control2 Interventions
Patients randomized to the intervention arm will be provided a single oral dose of prophylactic oral antibiotic at the time of cystoscopic stent removal
Group II: No AntibioticActive Control1 Intervention
Patients randomized to the non-intervention arm will not undergo prophylaxis at the time of cystoscopic stent removal

Find a Location

Who is running the clinical trial?

University of California, San DiegoLead Sponsor
1,121 Previous Clinical Trials
1,520,844 Total Patients Enrolled
6 Trials studying Kidney Stones
3,712 Patients Enrolled for Kidney Stones
Genesis HealthCareOTHER
1 Previous Clinical Trials
197,692 Total Patients Enrolled

Media Library

Ciprofloxacin (Antibiotic) Clinical Trial Eligibility Overview. Trial Name: NCT02944825 — N/A
Kidney Stones Research Study Groups: Antibiotic, No Antibiotic
Kidney Stones Clinical Trial 2023: Ciprofloxacin Highlights & Side Effects. Trial Name: NCT02944825 — N/A
Ciprofloxacin (Antibiotic) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02944825 — N/A
Kidney Stones Patient Testimony for trial: Trial Name: NCT02944825 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

In what ways is No Antibiotic commonly deployed in healthcare?

"No, Antibiotic is frequently used to combat otitis externa and additional conditions such as urinary tract infections related to entercococcus faecalis, bronchitis, or abdominal infection."

Answered by AI

Are there opportunities for volunteers to participate in this research project?

"The data hosted on clinicaltrials.gov shows that this research project is actively searching for participants. It was first revealed to the public on January 1st 2016 and its last update occured in March 2020."

Answered by AI

What prior investigations have been done regarding the use of No Antibiotic?

"Presently, there are 39 research studies being conducted on No Antibiotic therapy. 6 of these active trials fall within Phase 3 and the bulk of them are in Durham, North carolina; however, 75 sites across the country have begun implementing this type of treatment."

Answered by AI

How many participants are allowed to join this research project?

"Affirmative. Per clinicaltrials.gov, this medical trial is open for recruitment; it was first published on the 1st of January 2016 and its last update happened on March 23rd 2020. 80 patients must be enrolled at a single centre to complete the study."

Answered by AI

Who else is applying?

What state do they live in?
California
What site did they apply to?
University of California, San Diego
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0

Why did patients apply to this trial?

It s the only one I found.
PatientReceived no prior treatments
~6 spots leftby Jan 2025